127 related articles for article (PubMed ID: 35641264)
21. Targeting the DNA Damage Response in OSCC with TP53 Mutations.
Lindemann A; Takahashi H; Patel AA; Osman AA; Myers JN
J Dent Res; 2018 Jun; 97(6):635-644. PubMed ID: 29489434
[TBL] [Abstract][Full Text] [Related]
22. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
[TBL] [Abstract][Full Text] [Related]
23. RITA inhibits multiple myeloma cell growth through induction of p53-mediated caspase-dependent apoptosis and synergistically enhances nutlin-induced cytotoxic responses.
Saha MN; Jiang H; Mukai A; Chang H
Mol Cancer Ther; 2010 Nov; 9(11):3041-51. PubMed ID: 21062913
[TBL] [Abstract][Full Text] [Related]
24. Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells.
Ichwan SJ; Yamada S; Sumrejkanchanakij P; Ibrahim-Auerkari E; Eto K; Ikeda MA
Oncogene; 2006 Feb; 25(8):1216-24. PubMed ID: 16247456
[TBL] [Abstract][Full Text] [Related]
25. The regulation of long non-coding RNA 00958 (LINC00958) for oral squamous cell carcinoma (OSCC) cells death through absent in melanoma 2 (AIM2) depending on microRNA-4306 and Sirtuin1 (SIRT1) in vitro.
Jiang L; Ge W; Cui Y; Wang X
Bioengineered; 2021 Dec; 12(1):5085-5098. PubMed ID: 34384029
[TBL] [Abstract][Full Text] [Related]
26. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma.
Shi Y; Xie T; Wang B; Wang R; Cai Y; Yuan B; Gleber-Netto FO; Tian X; Rodriguez-Rosario AE; Osman AA; Wang J; Pickering CR; Ren X; Sikora AG; Myers JN; Rangel R
Commun Biol; 2022 Jul; 5(1):757. PubMed ID: 35902768
[TBL] [Abstract][Full Text] [Related]
27.
Shi Y; Ren X; Cao S; Chen X; Yuan B; Brasil da Costa FH; Rodriguez Rosario AE; Corona A; Michikawa C; Veeramachaneni R; Osman AA; Xie T; Wang W; Sikora AG; Myers JN; Rangel R
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604640
[TBL] [Abstract][Full Text] [Related]
28. RITA enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis.
Kazemi A; Safa M; Shahbazi A
Hematology; 2011 Jul; 16(4):225-31. PubMed ID: 21756539
[TBL] [Abstract][Full Text] [Related]
29. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598
[TBL] [Abstract][Full Text] [Related]
30. Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA.
Zhao CY; Grinkevich VV; Nikulenkov F; Bao W; Selivanova G
Cell Cycle; 2010 May; 9(9):1847-55. PubMed ID: 20436301
[TBL] [Abstract][Full Text] [Related]
31. RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity.
Ristau J; van Hoef V; Peuget S; Zhu J; Guan BJ; Liang S; Hatzoglou M; Topisirovic I; Selivanova G; Larsson O
Cell Death Dis; 2019 Nov; 10(11):845. PubMed ID: 31699971
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of Cisplatin Cytotoxicity by Cu(II)-Mn(II) Schiff Base Tetradentate Complex in Human Oral Squamous Cell Carcinoma.
Al-Serwi RH; Othman G; Attia MA; Enan ET; El-Sherbiny M; Mahmoud S; Elsherbiny N
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066414
[TBL] [Abstract][Full Text] [Related]
33. LINC00961 suppresses cell proliferation and induces cell apoptosis in oral squamous cell carcinoma.
Pan LN; Sun YR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3358-3365. PubMed ID: 31081090
[TBL] [Abstract][Full Text] [Related]
34. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
35. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
36. Re-expression of DIRAS3 and p53 induces apoptosis and impaired autophagy in head and neck squamous cell carcinoma.
Liu Z; Hurst DR; Qu X; Lu LG; Wu CZ; Li YY; Li Y
Mil Med Res; 2020 Oct; 7(1):48. PubMed ID: 33038921
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis and expression of Bax and Bcl-2 in snuff- and non-snuff associated oral squamous cell carcinomas.
Loro LL; Vintermyr OK; Ibrahim SO; Idris AM; Johannessen AC
Anticancer Res; 2000; 20(5A):2855-60. PubMed ID: 11062693
[TBL] [Abstract][Full Text] [Related]
38. The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines.
Choi HS; Kim YK; Yun PY
Mol Biol Rep; 2019 Feb; 46(1):617-625. PubMed ID: 30478746
[TBL] [Abstract][Full Text] [Related]
39. Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors.
Han HY; Lee HE; Kim HJ; Jeong SH; Kim JH; Kim H; Ryu MH
J Ethnopharmacol; 2016 Nov; 192():431-441. PubMed ID: 27616033
[TBL] [Abstract][Full Text] [Related]
40. Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance.
Alam M; Kashyap T; Mishra P; Panda AK; Nagini S; Mishra R
Head Neck; 2019 Jan; 41(1):185-197. PubMed ID: 30549344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
